But 'very weak' isn't 'zero.' At very high, supra-physiological doses not typically used in responsible research, some minor, transient elevations might be observed
Diagnosis of cerebral amyloid angiopathy
The higher dose produced results comparable to tirzepatide, suggesting that dose intensity is a significant variable in GLP-1 agonist efficacy
104 KabatJ.KrlP
Research demonstrates improvements in sleep onset latency, total sleep duration, sleep efficiency, and subjective sleep quality ratings without next-day drowsiness, cognitive impairment, or tolerance development
Florence Mowlem 1 1 uMotif, London, UK Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :210.4 Aims Digital data capture has become the mainstream method of capturing patient-reported outcome measures (PROMs)